Egyptian Drug Makers Agrees To Acquisition By U.K.'s Hikma
This article was originally published in PharmAsia News
Executive Summary
The Egyptian Company for Pharmaceuticals & Chemical Industries has agreed to an acquisition by U.K-based Hikma Pharmaceutical, for $22.2 million.